Myo inositol contributes to the normalization of the menstrual cycle and ovulation, functioning of the reproductive system of the body, and the proper embryonic development, as well as improves the overall metabolism of organs and systems.
infertility due to anovulation in women with PCOS; immaturity of oocytes; absence of ovulation; insulin resistance in women with PCOS; hyperandrogenism (hirsutism), dysmenorrhea (oligo-/amenorrhea); poor quality of oocytes and resulting poor quality of embryos; polycystic ovaries; prevention of premature ovarian failure; primary prevention of gestational diabetes mellitus in patients with PCOS; prevention of macrosomia in PCOS; prevention of fetal congenital anomalies during planning for pregnancy and early pregnancy; primary prevention of early miscarriages in patients with PCOS.
1 sachet a day. Dissolve the contents of the sachet in 200 ml of room temperature water, mix thoroughly, and drink immediately. Duration of treatment: 3 to 6 months.
Do not use it if you are allergic to any ingredient of the dietary supplement. Do not exceed the recommended daily dose. It is recommended to consult a physician before use.
Store at 0 to 25°C in the original packaging. Store in a dry place. Protect from light. Keep out of reach of children. Do not use the product beyond the expiry date.
2 years.
Efferta Pharma Sp. z o.o. Spółka Komandytowa, 3 ul. Gdańska, Cząstków Mazowiecki, 05-152 Czosnów, Poland; made to order: Tanacetum s.r.o., Švabinského 1700/4, 702 00 Ostrava, Czech Republic.
Наименование, адрес и контактные данные (телефон, факс, электронная почта) организации на территории Республики Казахстан, принимающей претензии (предложения) по качеству лекарственных средств от потребителей и ответственной за пострегистрационное наблюдение за безопасностью лекарственного средства:
ТОО «КФК «Медсервис Плюс» 050004, Республика Казахстан, г. Алматы, ул. Маметовой, 54 Телефон/Факс: (727) 279 98 21 E-mail: pharmanadzor@medservice.kz